{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:05:37Z","timestamp":1785679537103,"version":"3.56.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.path.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T19:07:08Z","timestamp":1536001628000},"page":"523-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Updates in Effusion Cytology"],"prefix":"10.1016","volume":"11","author":[{"given":"Christin M.","family":"Lepus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cncy.21518","article-title":"The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience","volume":"123","author":"Rossi","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1097-0339(199906)20:6<350::AID-DC5>3.0.CO;2-7","article-title":"Diagnostic accuracy of effusion cytology","volume":"20","author":"Motherby","year":"1999","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archinte.1987.00370060129021","article-title":"Malignant pleural effusions. A clinical cytopathologic study","volume":"147","author":"Irani","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.path.2018.05.003_bib4","article-title":"Performance characteristics of body fluid cytology: analysis of 344, 380 responses from the College of American Pathologists interlaboratory comparison program in nongynecologic cytopathology","author":"Tabatabai","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2018.05.003_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2303.2007.00468.x","article-title":"Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions","volume":"19","author":"Metzgeroth","year":"2008","journal-title":"Cytopathology"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib6","first-page":"290","article-title":"Pleural effusion cytology due to malignancy. A combined cytomorphological-immunocytochemical study of 500 cases","volume":"22","author":"Kalogeraki","year":"2016","journal-title":"Rev Port Pneumol (2006)"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib7","first-page":"367","article-title":"Lung cancer cytology: potential pitfalls and mimics - a review","volume":"3","author":"Idowu","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cncr.9044","article-title":"Immunocytochemistry in effusion cytology: a contemporary review","volume":"93","author":"Fetsch","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/dc.21389","article-title":"Immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma","volume":"39","author":"Shabaik","year":"2011","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"10.1016\/j.path.2018.05.003_bib10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0b013e3182960fa7","article-title":"ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas","volume":"37","author":"Sholl","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/his.12560","article-title":"Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer","volume":"66","author":"Zhou","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2018.05.003_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/annonc\/mdv489","article-title":"Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies","volume":"27","author":"Ilie","year":"2016","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.path.2018.05.003_bib13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/dc.23607","article-title":"Metastatic breast carcinoma in pleural fluid: correlation of receptor and HER2 status with the primary carcinoma \u2013 a pilot study","volume":"44","author":"Francis","year":"2016","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clbc.2015.03.010","article-title":"Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease","volume":"15","author":"Rossi","year":"2015","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000448325","article-title":"Flow cytometry and effusions in lymphoproliferative processes and other hematologic neoplasias","volume":"60","author":"Bode-Lesniewska","year":"2016","journal-title":"Acta Cytol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jcp.53.7.513","article-title":"Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings","volume":"53","author":"Risberg","year":"2000","journal-title":"J\u00a0Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cncy.21270","article-title":"The marriage of cytology and cytogenetics","volume":"121","author":"Dal Cin","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib18","first-page":"247","article-title":"Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma","volume":"117","author":"Factor","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.path.2018.05.003_bib19","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.10923","article-title":"The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions","volume":"99","author":"Illei","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2018.05.003_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/dc.23318","article-title":"ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients","volume":"43","author":"Bozzetti","year":"2015","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib23","doi-asserted-by":"crossref","first-page":"e0117032","DOI":"10.1371\/journal.pone.0117032","article-title":"Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3121\/cmr.2.3.147","article-title":"The promise of molecular profiling for cancer identification and treatment","volume":"2","author":"Cross","year":"2004","journal-title":"Clin Med Res"},{"key":"10.1016\/j.path.2018.05.003_bib25","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2016-0108-RA","article-title":"Optimizing workflows and processing of cytologic samples for comprehensive analysis by next-generation sequencing: Memorial Sloan Kettering Cancer Center experience","author":"Tian","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cncy.21664","article-title":"Optimizing the DNA yield for molecular analysis from cytologic preparations","volume":"124","author":"Roy-Chowdhuri","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"10.1016\/j.path.2018.05.003_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cncy.21597","article-title":"Factors affecting the success of next-generation sequencing cytology specimens","volume":"123","author":"Roy-Chowdhuri","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncy.21276","article-title":"Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality","volume":"121","author":"Dejmek","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/modpathol.2013.122","article-title":"Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics","volume":"27","author":"Kanagal-Shamanna","year":"2014","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.path.2018.05.003_bib30","doi-asserted-by":"crossref","first-page":"e80478","DOI":"10.1371\/journal.pone.0080478","article-title":"Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel","volume":"8","author":"Scarpa","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib31","doi-asserted-by":"crossref","first-page":"e87651","DOI":"10.1371\/journal.pone.0087651","article-title":"Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions","volume":"9","author":"de Biase","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cncy.21666","article-title":"Using \u201cresidual\u201d FNA rinse and body fluid specimens for next-generation sequencing: an institutional experience","volume":"124","author":"Wei","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/SLA.0000000000001156","article-title":"Reliable detection of somatic mutations in fine needle aspirates of pancreatic cancer with next-generation sequencing: implications for surgical management","volume":"263","author":"Valero","year":"2016","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cncy.21260","article-title":"High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas","volume":"121","author":"Sun","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1158\/1078-0432.CCR-12-1958","article-title":"Effective assessment of EGFR mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing","volume":"19","author":"Buttitta","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib36","first-page":"30","article-title":"Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patient with adenocarcinoma of the lung","volume":"125","author":"Velizheva","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/AJCPVAGIUC1AHC3Y","article-title":"Epidermal growth factor receptor gene analysis with a highly sensitive molecular assay in routine cytologic specimens of lung adenocarcinoma","volume":"138","author":"Allegrini","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.path.2018.05.003_bib38","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/jclinpath-2013-201728","article-title":"The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies","volume":"66","author":"Liu","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1373\/clinchem.2014.225565","article-title":"Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations","volume":"60","author":"Liu","year":"2014","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/gcc.22509","article-title":"Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility","volume":"57","author":"Leichsenring","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.path.2018.05.003_bib41","first-page":"786","article-title":"Next-generation sequencing of cytologic preparations: an analysis of quality metrics","volume":"125","author":"Hwang","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cncy.21522","article-title":"Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma","volume":"123","author":"Shah","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2016.05.017","article-title":"Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma","volume":"17","author":"DiBardino","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/JTO.0b013e318290868f","volume":"8","author":"Lindeman","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cncy.21246","article-title":"Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period","volume":"121","author":"Dragoescu","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1513\/pats.200510-113JH","article-title":"Parapneumonic effusions and empyema","volume":"3","author":"Light","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s100960050270","article-title":"Prospective clinical and microbiological study of pleural effusions","volume":"18","author":"Ferrer","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0002-8703(99)70500-4","article-title":"Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature","volume":"137","author":"Chen","year":"1999","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rmed.2007.11.014","article-title":"Pleural effusion in hospitalized patients with Coccidioidomycosis","volume":"102","author":"Merchant","year":"2008","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00063198-200307000-00002","article-title":"Eosinophilic pleural effusions","volume":"9","author":"Kalomenidis","year":"2003","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1309\/EXBVYAUPENBM285Y","article-title":"Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination","volume":"119","author":"Tarrand","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib52","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.path.2018.05.003_bib53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.7326\/0003-4819-118-11-199306010-00005","article-title":"Pleural effusions in hospitalized patients with AIDS","volume":"118","author":"Joseph","year":"1993","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/AJCP99OOOZSNISCZ","article-title":"Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution","volume":"131","author":"Sangoi","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib55","article-title":"Diagnostic accuracy of fungal identification in histopathology and cytopathology specimens","author":"Kung","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.path.2018.05.003_bib56","doi-asserted-by":"crossref","first-page":"e0165428","DOI":"10.1371\/journal.pone.0165428","article-title":"Clinical and laboratory differences between lymphocyte- and neutrophil-predominant pleural tuberculosis","volume":"11","author":"Choi","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib57","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1309\/AJCP3C3BVARTZZWX","article-title":"Epstein-Barr virus-positive pleural effusion: clinical features, cytomorphologic characteristics, and flow cytometric immunophenotyping","volume":"142","author":"Takei","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib58","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1183\/09031936.05.00131204","article-title":"A\u00a0possible role for Epstein-Barr virus in the pathogenesis of pleural effusion","volume":"26","author":"Thijsen","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.path.2018.05.003_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jctube.2016.05.005","article-title":"Diagnosis of active tuberculosis disease: from microscopy to molecular techniques","volume":"4","author":"Caulfield","year":"2016","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2303.1992.tb00014.x","article-title":"Cytological aspects of pleural, peritoneal and pericardial fluids from patients with systemic lupus erythematosus","volume":"3","author":"Naylor","year":"1992","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.26.6.467","article-title":"Rheumatoid pleuritis","volume":"26","author":"Walker","year":"1967","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib62","first-page":"465","article-title":"The pathognomonic cytologic picture of rheumatoid pleuritis. The 1989 Maurice Goldblatt Cytology award lecture","volume":"34","author":"Naylor","year":"1990","journal-title":"Acta Cytol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0954-6111(99)90022-7","article-title":"Analysis of pleural fluid in idiopathic spontaneous pneumothorax; correlation of eosinophil percentage with the duration of air in the pleural space","volume":"93","author":"Smit","year":"1999","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00000441-200609000-00011","article-title":"Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax","volume":"332","author":"Heidecker","year":"2006","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1759-7714.12271","article-title":"Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis","volume":"7","author":"Ebata","year":"2016","journal-title":"Thorac Cancer"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib66","first-page":"425","article-title":"Utility of cell block, to detect malignancy in fluid cytology: adjunct or necessity?","volume":"13","author":"Dey","year":"2017","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib67","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000329817","article-title":"Pleural effusion in women\u00a0with a known adenocarcinoma: the role of immunostains in uncovering another hidden primary tumor","volume":"55","author":"Nasser","year":"2011","journal-title":"Acta Cytol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib68","first-page":"128","article-title":"Diagnostic yield of cytopathology in evaluating pericardial effusions: clinicopathologic analysis of 419 specimens","volume":"125","author":"Saab","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ordonez","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncy.21392","article-title":"Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology","volume":"122","author":"Jo","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/j.path.2018.05.003_bib71","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/JTO.0b013e318267223a","article-title":"Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small cell lung cancer","volume":"7","author":"Morgensztern","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib72","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/path.1566","article-title":"CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas","volume":"203","author":"Yatabe","year":"2004","journal-title":"J\u00a0Pathol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000326954","article-title":"Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from on-pulmonary adenocarcinoma in pleural effusion","volume":"55","author":"Kim","year":"2011","journal-title":"Acta Cytol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/dc.23442","article-title":"Utility of TTF-1 and Napsin-A in the work-up of malignant effusions","volume":"44","author":"El Hag","year":"2016","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cncr.10310","article-title":"Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens","volume":"96","author":"Ng","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.path.2018.05.003_bib76","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/dc.20667","article-title":"(TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions","volume":"35","author":"Dejmek","year":"2007","journal-title":"Diagn Cytopathol"},{"issue":"8","key":"10.1016\/j.path.2018.05.003_bib77","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/modpathol.2013.34","article-title":"Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma","volume":"26","author":"Ordonez","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib78","unstructured":"The cBioPortal for Cancer Genomics. Available at:\u00a0http:\/\/www.cbioportal.org\/index.do. Accessed December 14, 2017."},{"issue":"269","key":"10.1016\/j.path.2018.05.003_bib79","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"16","key":"10.1016\/j.path.2018.05.003_bib81","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1158\/1078-0432.CCR-17-0540","article-title":"U.S. Food and Drug Administration approval summary: atezolizumab for metastatic non-small cell lung cancer","volume":"23","author":"Weinstock","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2018.05.003_bib82","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1470-2045(16)30498-3","article-title":"Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study","volume":"17","author":"Langer","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.path.2018.05.003_bib83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/cncy.21937","article-title":"Programmed death-ligand 1 expression in non-small cell lung carcinoma: comparison among cytology, small biopsy, and surgical resection specimens","volume":"125","author":"Heymann","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dc.21039","article-title":"Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens","volume":"37","author":"Yan","year":"2009","journal-title":"Diagn Cytopathol"},{"issue":"10","key":"10.1016\/j.path.2018.05.003_bib85","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncy.21574","article-title":"Young investigator challenge: the utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions","volume":"123","author":"Lew","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib86","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dc.23206","article-title":"Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens","volume":"43","author":"Braxton","year":"2015","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncy.21393","article-title":"GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens","volume":"122","author":"Shield","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.path.2018.05.003_bib88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.humpath.2017.08.011","article-title":"Utility of Sox10 labeling in metastatic breast carcinomas","volume":"67","author":"Nelson","year":"2017","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.path.2018.05.003_bib89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/dc.21442","article-title":"Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic M\u00fcllerian carcinoma in effusions","volume":"39","author":"Wiseman","year":"2011","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2014.07.100","article-title":"Lynch syndrome in patients with clear cell and endometrioid cancers of the ovary","volume":"135","author":"Vierkoetter","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.path.2018.05.003_bib91","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2303.2004.00140.x","article-title":"Peritoneal washing cytology","volume":"15","author":"Shield","year":"2004","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib93","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/cyt.12297","article-title":"Cytomorphology of ovarian clear cell carcinomas in peritoneal effusions","volume":"27","author":"Damiani","year":"2016","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib94","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1309\/AJCP8WO2EOIAHSOF","article-title":"The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary","volume":"142","author":"Kandalaft","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A\u00a0limited panel of immunomarkers can reliably distinguish between clear cell and high grade serous carcinoma of the ovary","volume":"33","author":"Kobel","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2018.05.003_bib96","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/PAS.0000000000000935","article-title":"PAX8 expression in a subset of malignant peritoneal mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2018.05.003_bib97","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib98","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jcp.2003.013615","article-title":"CDX-2 immunostaining in primary and secondary ovarian carcinomas","volume":"57","author":"Tomillo","year":"2004","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib99","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1746-1596-8-106","article-title":"Clinicopathologic correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer","volume":"8","author":"Nodin","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1746-1596-7-9","article-title":"The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: CK7-\/20+ phenotype is more specific than CDX2 antibody","volume":"7","author":"Bayrak","year":"2012","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9440(10)64703-7","article-title":"Immunohistochemical labeling for dpc4 mirrors genetic status\u00a0in pancreatic adenocarcinomas: a new marker of DPC4 inactivation","volume":"156","author":"Wilentz","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib102","article-title":"HER2 status in gastric and gastroesophageal junction cancer: results of the large, multinational HER-EAGLE study","author":"Kim","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib103","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000056290","article-title":"Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients","volume":"67","author":"Senyigit","year":"2000","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib104","first-page":"182","article-title":"Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death","volume":"45","author":"Ribak","year":"1988","journal-title":"Br J Ind Med"},{"issue":"10","key":"10.1016\/j.path.2018.05.003_bib105","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.path.2018.05.003_bib106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0003-4878(00)00045-4","article-title":"The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure","volume":"44","author":"Hodgson","year":"2000","journal-title":"Ann Occup Hyg"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/19338240903390305","article-title":"Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors","volume":"65","author":"Metintas","year":"2010","journal-title":"Arch Environ Occup Health"},{"key":"10.1016\/j.path.2018.05.003_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1742-6413.170726","volume":"12","author":"Hjerpe","year":"2015","journal-title":"Cytojournal"},{"key":"10.1016\/j.path.2018.05.003_bib109","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1378\/chest.111.1.106","article-title":"The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma","volume":"111","author":"Renshaw","year":"1997","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.path.2018.05.003_bib110","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/dc.21303","article-title":"The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma","volume":"38","author":"Rakha","year":"2010","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib111","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/dc.21398","article-title":"Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations","volume":"39","author":"Ikeda","year":"2011","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib112","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncy.20071","article-title":"The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in\u00a0cytologic effusions","volume":"118","author":"Hasteh","year":"2010","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.path.2018.05.003_bib113","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPWFW7O1FVFLKT","article-title":"Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids","volume":"131","author":"Shen","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","article-title":"The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor receptor, P-glycoprotein, and Bcl-2","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/AJCP5KNL7QTELLYI","article-title":"Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells","volume":"141","author":"Minato","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2018.05.003_bib116","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib117","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2018.05.003_bib118","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.path.2018.05.003_bib119","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5858\/arpa.2015-0508-LE","article-title":"Immunohistochemistry for NF2, LATS1\/2, and TAP\/TAZ fails to separate benign from malignant mesothelial proliferations","volume":"140","author":"Sheffield","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2018.05.003_bib121","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.path.2018.05.003_bib122","article-title":"Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions","author":"Cozzi","year":"2017","journal-title":"Diagn Cytopathol"},{"issue":"7","key":"10.1016\/j.path.2018.05.003_bib123","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/dc.21578","article-title":"Low cost-effectiveness of CD3\/CD20 immunostains for initial triage of lymphoid-rich effusions: an evidence-based review of the utility of these stains in selecting cases for full hematopathologic workup","volume":"40","author":"Walts","year":"2012","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2018.05.003_bib124","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cncy.21257","article-title":"Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience","volume":"121","author":"Tong","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.path.2018.05.003_bib125","article-title":"An algorithmic approach to diagnose haematolymphoid neoplasms in effusion by combining morphology, immunohistochemistry, and molecular cytogenetics","author":"Chen","year":"2017","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ajcp\/106.3.359","article-title":"Cytologic diagnosis of primary serous lymphoma","volume":"106","author":"Jones","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib127","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00042560-199611010-00003","article-title":"The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions","volume":"13","author":"Komanduri","year":"1996","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"3","key":"10.1016\/j.path.2018.05.003_bib128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.thj.6200096","article-title":"A\u00a0clinical, molecular, and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients","volume":"2","author":"Boulanger","year":"2001","journal-title":"Hematol J"},{"issue":"9","key":"10.1016\/j.path.2018.05.003_bib129","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.3880635","article-title":"Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8","volume":"15","author":"Wakely","year":"2002","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0142(19980425)84:2<71::AID-CNCR1>3.0.CO;2-G","article-title":"Cytologic features of sarcomas in fluids","volume":"84","author":"Abadi","year":"1998","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.003_bib131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0046-8177(00)80194-X","article-title":"Malignant epithelioid vascular tumors of the pleura: report of a series and literature review","volume":"31","author":"Zhang","year":"2000","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib132","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000357967","article-title":"Cytomorphological features of epithelioid hemangioendothelioma in ascitic fluid with radiological, clinical, and histopathological correlations","volume":"58","author":"Enbom","year":"2014","journal-title":"Acta Cytol"},{"issue":"2","key":"10.1016\/j.path.2018.05.003_bib133","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/PXMU-LF05-3894-W29F","article-title":"Cytology of angiosarcoma. Findings in fourteen fine-needle aspiration biopsy specimens and one pleural fluid specimen","volume":"114","author":"Boucher","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2018.05.003_bib134","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/JTO.0000000000000545","article-title":"Primary pulmonary NUT midline carcinoma: clinical, radiographic, and pathologic characterizations","volume":"10","author":"Sholl","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"12","key":"10.1016\/j.path.2018.05.003_bib135","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/cncy.21761","article-title":"Cytopathologic features of NUT midline carcinoma: a series of 26 specimens from 13 patients","volume":"124","author":"Bishop","year":"2016","journal-title":"Cancer Cytopathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:41:20Z","timestamp":1761748880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918118300357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1875918118300357"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2018.05.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in Effusion Cytology","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}